Resverlogix Corp Stock Today
| RVXCF Stock | USD 0.04 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Resverlogix Corp is trading at 0.04 as of the 3rd of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.04. Resverlogix Corp has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Resverlogix Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of December 2022 and ending today, the 3rd of December 2024. Click here to learn more.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company has 265.27 M outstanding shares. More on Resverlogix Corp
Moving against Resverlogix Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Resverlogix Pink Sheet Highlights
| CEO | Donald McCaffrey |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Resverlogix Corp [RVXCF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resverlogix Corp's market, we take the total number of its shares issued and multiply it by Resverlogix Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Resverlogix Corp classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 265.27 M outstanding shares.
Resverlogix Corp has accumulated about 42 K in cash with (8.02 M) of positive cash flow from operations.
Check Resverlogix Corp Probability Of Bankruptcy
Ownership AllocationResverlogix Corp owns a total of 265.27 Million outstanding shares. Resverlogix Corp has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Resverlogix Ownership Details
Resverlogix Corp Risk Profiles
| Mean Deviation | 3.4 | |||
| Standard Deviation | 8.95 | |||
| Variance | 80.13 | |||
| Risk Adjusted Performance | (0.01) |
Resverlogix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Resverlogix Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Other Information on Investing in Resverlogix Pink Sheet
Resverlogix Corp financial ratios help investors to determine whether Resverlogix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resverlogix with respect to the benefits of owning Resverlogix Corp security.